CAR-T cells: the narrow path between hope and bankruptcy?

Affiliations

• ¹ Institut Paoli-Calmettes, Inserm CBT-1409 & Aix-Marseille Université, Marseille, France.
• ² Laboratory of Translational Immunology & Department of Hematology, UMC Utrecht, Utrecht, The Netherlands.
• ³ EBMT Legal & Regulatory Affairs Committee of EBMT, Barcelona, Spain.
• ⁴ Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany.
• ⁵ Hematology Unit, G. Gaslini, Research Children's Hospital, Genova, Italy.
• ⁶ Department of Pediatrics, Division of Stem Cell Transplantation, Leiden University Medical Center, Leiden, The Netherlands.
• ⁷ Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
• ⁸ Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
• ⁹ Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
• ¹⁰ Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
• ¹¹ Department of Pediatric Hematology and Oncology; Collegium Medicum; Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
• ¹² Hospital Puerta de Hierro - Universidad Autónoma de Madrid, Madrid, Spain.
• ¹³ Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
• ¹⁴ Hôpital Saint-Antoine, Université Pierre & Marie Curie and INSERM, Paris, France.